Anti-Kallikrein 9 Antibody | Boster Immunoleader PA1820 product information

product summary

request information :

company name :

Boster Immunoleader

product type :

antibody

product name :

Anti-Kallikrein 9 Antibody

catalog :

PA1820

quantity :

100 ug/vial

price :

200 USD

clonality :

polyclonal

host :

rabbit

reactivity :

human

application :

western blot

more info or order :

Boster Immunoleader product webpage

product information

Product Name :

Anti-Kallikrein 9 Antibody

Catalog Number :

PA1820

Clonality :

Polyclonal

Description short :

Rabbit IgG polyclonal antibody for Kallikrein-9(KLK9) detection. Tested with WB in Human.

Price :

200 USD

Ig type :

Rabbit IgG

Size :

100 ug/vial

Form :

Lyophilized

Specificity :

No cross reactivity with other proteins.

Reactivity :

Reacts with: human

Applications :

Western blot :

Concentration: 0.1-0.5μg/ml; Tested Species: Human

Notes :

Tested Species: In-house tested species with positive results. Predicted Species: Species predicted to be fit for the product based on sequence similarities. Other applications have not been tested. Optimal dilutions should be determined by end users.

Immunogen :

A synthetic peptide corresponding to a sequence at the C-terminus of human Kallikrein 9(236-250aa SVCHYLDWIQEIMEN).

Contents :

Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3.

Purification :

Immunogen affinity purified.

Reconstitution :

Add 0.2ml of distilled water will yield a concentration of 500ug/ml.

Storage :

At -20˚C for one year. After reconstitution, at 4˚C for one month. It can also be aliquotted and stored frozen at -20˚C for a longer time. Avoid repeated freezing and thawing.

Relevant detection systems :

Boster provides a series of assays reacted with primary antibodies. Antibody can be supported by chemiluminescence kit EK1002 in WB.

Background :

KLK9(kallikrein-related peptidase 9) also known as kallikrein 9 or KLK-L3, belongs to the kallikrein subgroup of serine proteases, which have diverse physiologic functions in many tissues. The KLK9 gene contains 5 coding exons and is mapped to 19q13.41. The KLK9 gene is regulated by steroid hormones in a human breast cancer cell line. Yousef et al.(2001) performed a quantitative analysis of KLK9 expression in ovarian cancer. The results indicated thatKLK9 is under steroid hormone regulation in ovarian and breast cancer cell lines. KLK9 is a potential independent favorable prognostic marker for early-stage, low-grade, optimally debulked ovarian cancer patients.

Reference :

1. Yousef, G. M., Diamandis, E. P. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9). Genomics 65: 184-194, 2000. 2. Yousef, G. M., Kyriakopoulou, L. G., Scorilas, A., Fracchioli, S., Ghiringhello, B., Zarghooni, M., Chang, A., Diamandis, M., Giardina, G., Hartwick, W. J., Richiardi, G., Massobrio, M., Diamandis, E. P., Katsaros, D. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res. 61: 7811-7818, 2001.

Gene Name :

KLK9

Protein Name :

Kallikrein-9

Gene Full Name :

kallikrein-related peptidase 9

Synonyms :

Kallikrein 8 antibody Kallikrein 9 antibody Kallikrein L3 antibody Kallikrein Like 3 antibody Kallikrein like protein 3 antibody kallikrein related peptidase 9 antibody Kallikrein-9 antibody Kallikrein-like protein 3 antibody Kallikrein8 antibody Kallikrein9 antibody KLK 8 antibody KLK 9 antibody KLK L3 antibody KLK-L3 antibody KLK8 antibody KLK9 antibody KLK9_HUMAN antibody KLKL 3 antibody KLKL3 antibody

Uniprot ID :

Q9UKQ9

more info or order :

Boster Immunoleader product webpage